Cargando…
Intravitreal Corticosteroid Implantation in Diabetic Macular Edema: Updated European Consensus Guidance on Monitoring and Managing Intraocular Pressure
Intravitreal therapy for diabetic macular edema can, in susceptible patients, increase intraocular pressure (IOP). As uncontrolled IOP can potentially be sight threatening, monitoring is an essential component of patient management. It can be challenging for retina specialists to ensure that monitor...
Autores principales: | Goñi, Francisco J., Barton, Keith, Dias, José António, Diestelhorst, Michael, Garcia-Feijoo, Julián, Hommer, Anton, Kodjikian, Laurent, Nicolò, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770785/ https://www.ncbi.nlm.nih.gov/pubmed/34993882 http://dx.doi.org/10.1007/s40123-021-00427-1 |
Ejemplares similares
-
Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management
por: Goñi, Francisco J., et al.
Publicado: (2016) -
INTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA: Pharmacokinetic Considerations
por: Yang, Yit, et al.
Publicado: (2015) -
Intravitreal triamcinolone for intraocular inflammation and associated macular edema
por: Couch, Steven M, et al.
Publicado: (2009) -
Two-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
por: Tran, Thi Ha Chau, et al.
Publicado: (2022) -
Intravitreal corticosteroid implant vs intravitreal ranibizumab for the treatment of macular edema: a meta-analysis of randomized controlled trials
por: Wei, Qingquan, et al.
Publicado: (2019)